Your browser doesn't support javascript.
loading
PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer.
van Loon, Judith; Even, Aniek J G; Aerts, Hugo J W L; Öllers, Michel; Hoebers, Frank; van Elmpt, Wouter; Dubois, Ludwig; Dingemans, Anne-Marie C; Lalisang, Roy I; Kempers, Pascal; Brans, Boudewijn; Winnepenninckx, Véronique; Speel, Ernst-Jan; Thunnissen, Eric; Smits, Kim M; Boellaard, Ronald; Vugts, Danielle J; De Ruysscher, Dirk; Lambin, Philippe.
Afiliação
  • van Loon J; Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands. Electronic address: Judith.vanloon@maastro.nl.
  • Even AJG; Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands.
  • Aerts HJWL; Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands; Departments of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
  • Öllers M; Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands.
  • Hoebers F; Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands.
  • van Elmpt W; Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands.
  • Dubois L; Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands.
  • Dingemans AC; Department of Pulmonology, Maastricht University Medical Centre, The Netherlands.
  • Lalisang RI; Department of Medical Oncology, Maastricht University Medical Centre, The Netherlands.
  • Kempers P; Department of Nuclear Medicine, Maastricht University Medical Centre, The Netherlands.
  • Brans B; Department of Nuclear Medicine, Maastricht University Medical Centre, The Netherlands.
  • Winnepenninckx V; Department of Pathology, Maastricht University Medical Centre, The Netherlands.
  • Speel EJ; Department of Pathology, Maastricht University Medical Centre, The Netherlands.
  • Thunnissen E; Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands.
  • Smits KM; Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands.
  • Boellaard R; Department of Radiology and Nuclear Medicine, VU University Medical Centre, Amsterdam, The Netherlands.
  • Vugts DJ; Department of Radiology and Nuclear Medicine, VU University Medical Centre, Amsterdam, The Netherlands.
  • De Ruysscher D; Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands; Department of Radiation Oncology, University Hospital Leuven, KU Leuven, Belgium.
  • Lambin P; Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands.
Radiother Oncol ; 122(2): 267-273, 2017 02.
Article em En | MEDLINE | ID: mdl-28012793

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Zircônio / Carcinoma Pulmonar de Células não Pequenas / Tomografia por Emissão de Pósitrons / Cetuximab / Neoplasias de Cabeça e Pescoço / Neoplasias Pulmonares / Antineoplásicos Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Radiother Oncol Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Zircônio / Carcinoma Pulmonar de Células não Pequenas / Tomografia por Emissão de Pósitrons / Cetuximab / Neoplasias de Cabeça e Pescoço / Neoplasias Pulmonares / Antineoplásicos Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Radiother Oncol Ano de publicação: 2017 Tipo de documento: Article